I

InnoCare Pharma 诺诚健华(HKEX: 09969; SSE: 688428)

103 employees

InnoCare is a Chinese biopharmaceutical company that develops treatment for cancer and autoimmune diseases.

Basic info

Industry

biotechnology research

Sectors

Medical research
Biotechnology
Oncology diseases
New drug discovery
Pharmacology
Pharmaceutical
Discovery biology
Medicinal Chemistry
Health Care
Clinical development
CMC
Autoimmune diseases

Date founded

2013

Funding rounds raised

Total raised

$160M

from 5 investors over 5 rounds

I

InnoCare Pharma 诺诚健华(HKEX: 09969; SSE: 688428) raised undisclosed on February 3, 2021

Investors: Hillhouse Capital Management and Vivo Capital

I

InnoCare Pharma 诺诚健华(HKEX: 09969; SSE: 688428) raised $160M on January 3, 2019

Investors: Loyal Valley Capital and Vivo Capital

I

InnoCare Pharma 诺诚健华(HKEX: 09969; SSE: 688428) raised $55M on February 9, 2018

Investors: Vivo Capital

FAQ